Role of EGFR, HER2 and PIK3CA alterations in male breast cancer

被引：0
|
作者：
Rizzolo, P. [1 ]
Silvestri, V. [1 ]
Falchetti, M. [1 ]
Zanna, I. [2 ]
Palli, D. [2 ]
Ottini, L. [1 ]
机构：
[1] Univ Roma La Sapienza, Rome, Italy
[2] Canc Prevent & Res Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)70901-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
92
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [31] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [32] Pattern of PIK3CA co-alterations in endometrial cancer
    Paul, Madhuri
    Scarpa, Frank J.
    Daringer, Rachel
    Agersborg, Sally
    Funari, Vincent Anthony
    Blocker, Forrest
    CANCER RESEARCH, 2022, 82 (12)
  • [33] PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer
    Deb, Siddhartha
    Do, Hongdo
    Byrne, David
    Jene, Nicholas
    Dobrovic, Alexander
    Fox, Stephen B.
    BREAST CANCER RESEARCH, 2013, 15 (04):
  • [34] Mutation of the PIK3CA gene in ovarian and breast cancer
    Campbell, IG
    Russell, SE
    Choong, DYH
    Montgomery, KG
    Ciavarella, ML
    Hooi, CSF
    Cristiano, BE
    Pearson, RB
    Phillips, WA
    CANCER RESEARCH, 2004, 64 (21) : 7678 - 7681
  • [35] PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
    Migliaccio, Ilenia
    Paoli, Marta
    Risi, Emanuela
    Biagioni, Chiara
    Biganzoli, Laura
    Benelli, Matteo
    Malorni, Luca
    NPJ BREAST CANCER, 2022, 8 (01)
  • [36] PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer
    Siddhartha Deb
    Hongdo Do
    David Byrne
    Nicholas Jene
    Alexander Dobrovic
    Stephen B Fox
    Breast Cancer Research, 15
  • [37] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [38] Characterization of PIK3CA mutations in lobular breast cancer
    Desmedt, C.
    Metzger
    Fumagalli, D.
    Brown, D.
    Singhal, S.
    Vincent, D.
    Adnet, P-Y
    Smeets, D.
    Berthed, F.
    Galant, C.
    Salgado, R.
    Veys, I.
    Saini, K.
    Pruneri, G.
    Krop, I.
    Winer, E.
    Michiels, S.
    Piccart, M.
    Lambrechts, D.
    Larsimont, D.
    Viale, G.
    Sotiriou, C.
    CANCER RESEARCH, 2012, 72
  • [39] Evaluation of PIK3CA mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project
    Peixoto, Ana
    Cirnes, Luis
    Carvalho, Ana Luisa
    Andrade, Maria Joao
    Brito, Maria Jose
    Borralho, Paula
    Borralho, Pedro M.
    Carneiro, Ana Sofia
    Castro, Lisandra
    Correia, Lurdes
    Dionisio, Maria Rita
    Faria, Carlos
    Figueiredo, Paulo
    Gomes, Ana
    Paixao, Joana
    Pinheiro, Manuela
    Prazeres, Hugo
    Ribeiro, Joana
    Salgueiro, Natalia
    Schmitt, Fernando C.
    Silva, Fatima
    Silvestre, Ana Rita
    Sousa, Ana Carla
    Almeida-Tavares, Joana
    Teixeira, Manuel R.
    Andre, Saudade
    Machado, Jose Carlos
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [40] Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
    Cizkova, M.
    Dujaric, M-E
    Lehmann-Che, J.
    Scott, V.
    Tembo, O.
    Asselain, B.
    Pierga, J-Y
    Marty, M.
    de Cremoux, P.
    Spyratos, F.
    Bieche, I.
    BRITISH JOURNAL OF CANCER, 2013, 108 (09) : 1807 - 1809
12345